Endocrine Today Current Issue

The following articles appeared in the print edition of Endocrine Today.

Table of Contents

• Evidence-based data needed to support ADA/EASD position statement
• ATA issues guidelines for anaplastic thyroid cancer management
• CDC: Diagnosed diabetes rate increasing nationwide
• Fasting for routine lipid screening deemed largely unnecessary
• Study finds obesity nearly doubles risk for severe distal fibula fractures
• Accountable care organizations and your new employee: Lady luck Richard O. Dolinar, MD
• The case for fellowship: Why I came back William Duke
• Man presents with swollen red, painful eyes and subclinical hyperthyroidism Stephanie L. Lee, MD, PhD, ECNU
• AACE urges more training in nutrition, health promotion
• Association between low vitamin D, clinical outcomes varied
• Cinacalcet failed to reduce risk for mortality, CV events in hyperparathyroidism
• Critical gaps exist in treatment options for older diabetics
• Diabetes more prevalent in countries using high fructose corn syrup
• Early menarche may predict overall obesity
• Gender, age affect lipids in hypothyroidism
• Genetic alterations responsible for male infertility identified
• High BMI does not contraindicate unicompartmental knee replacement
• High BMI, BP likely increases risk for death from prostate cancer
• Legumes improved glycemic control, reduced CHD risk score
• Life expectancy normal for most patients with differentiated thyroid cancer
• Liraglutide, exenatide produced similar results in type 2 diabetes
• Mayo Clinic: Quality of life not determined by prevalence of ApoE
• Odanacatib increased BMD in postmenopausal women
• Overweight adolescents at increased risk for end-stage renal disease
• Potassium citrate improved BMD in elderly patients on vitamin D, calcium
• Recombinant parathyroid hormone shows promise for hypoparathyroidism
• Researchers predict substantial increase in youth diabetes by 2050
• Study: SSI better predicted by distribution of body mass in obese patients
• Thyroid dysfunction in early pregnancy raised risk for gestational diabetes
• ASPIRE: VTE recurrence similar with aspirin, placebo
• CABG more cost effective than PCI for patients with diabetes
• Daily multivitamin failed to reduce major CVD risk in middle-aged men
• Dalcetrapib increased HDL, did not reduce risk for CV events
• FORWARD, OPERA: Omega-3 fatty acids do not reduce AF occurrence
• Guidelines program improved adherence among patients with diabetes, ACS
• NAFLD Fibrosis Score inaccurate in patients with elevated BMI
• Patients with NAFLD have more visceral fat, reduced muscle mass
• Prasugrel vs. clopidogrel linked with lower platelet reactivity in select patients
• RUTHERFORD: PCSK9 inhibition improved LDL in patients with familial hypercholesterolemia
• Safety of testosterone questioned in veterans with diabetes, CAD
• TACT: Chelation therapy reduced adverse events in post-MI patients
• UMPIRE: Polypill strategy improved adherence, systolic BP, LDL
• Antihyperglycemic agents on the horizon James R. Taylor, PharmD, CDE